Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets
ENRICH-AF
Approved small_molecule active
Quick answer
Lixiana 30 mg film-coated tablets, Lixiana 60 mg film-coated tablets for High risk atrial fibrillation patients with previous intracranial hemorrhage is a Approved program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- High risk atrial fibrillation patients with previous intracranial hemorrhage
- Phase
- Approved
- Modality
- small_molecule
- Status
- active